Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Obesity 1 Fistula 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Colonic Neoplasms 1 Bile Duct Neoplasms 1 Anastomotic Leak 1

Interventions

Gemcitabine 57 130-nm albumin-bound paclitaxel 35 Specimen Handling 26 Magnetic Resonance Spectroscopy 21 Albumin-Bound Paclitaxel 21 Fluorouracil 20 Leucovorin 19 Irinotecan 19 Oxaliplatin 17 Biopsy 17 Taxes 16 pembrolizumab 13 Cyclophosphamide 11 Cisplatin 11 fludarabine 10 Cetuximab 9 Capecitabine 8 Nivolumab 7 Carboplatin 7 irinotecan sucrosofate 6 durvalumab 6 dehydroftorafur 6 Radiosurgery 6 Pemetrexed 6 olaparib 5 Ipilimumab 5 Erlotinib Hydrochloride 5 trastuzumab deruxtecan 4 aldesleukin 4 Radiotherapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Stents × 90 days × Clear all

NCT06630910 2026-03-31

whipple

Theodor Bilharz Research Institute

Phase NA Completed

Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡